Compounds > 1,3-dipropyl-8-cyclopentylxanthine
Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Anterior Choroidal Artery Infarction

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Anterior Choroidal Artery Infarction in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, M1
Nakakimura, K1
Matsumoto, M1
Sakabe, T1
Xu, H1
Aibiki, M1
Nagoya, J1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Anterior Choroidal Artery Infarction

ArticleYear
Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2002, Volume: 22, Issue:2

    Topics: Adaptation, Physiological; Animals; Brain Ischemia; Cerebral Infarction; Cryoprotective Agents; Dime

2002
Neuroprotective effects of hyperthermic preconditioning on infarcted volume after middle cerebral artery occlusion in rats: role of adenosine receptors.
    Critical care medicine, 2002, Volume: 30, Issue:5

    Topics: Animals; Brain; Cerebral Infarction; Hyperthermia, Induced; Ischemic Preconditioning; Male; Middle C

2002